• Contact
  • Location
  • Sitemap
  • About
    • Company Profile
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
    • Careers
    • Contact
  • Technology
    • Immunicum’s Approach
    • Ilixadencel
    • Development Programs
    • Publications
  • Pipeline
    • Pipeline
    • Clinical Trial Information
  • Partnering
  • Investors
    • Overview
    • Press Releases
      • 2018
      • 2017
      • 2016
      • 2015
      • 2014
      • 2013
      • Subscribe
    • Events & Presentations
    • Corporate Governance
      • Articles of Association
      • General meeting
      • Board of directors
      • Corporate governance reports
      • Senior Executives
      • Nomination Committee
      • Remuneration and the remuneration committee
      • Auditors and audit committee
      • Scientific committee
      • Scientific Advisory Board
    • Shareholder & Stock Info
      • Shareholders
      • Insider
      • Investment calculator
      • Share price look-up
    • Financial Reports
    • Financial calendar
    • SECURED RIGHTS ISSUE 2017
    • Downloads
    • Contacts
  • Investerare (SE)
    • Översikt
    • Pressmeddelanden
      • 2018
      • 2017
      • 2016
      • 2015
      • 2014
      • 2013
      • Prenumerera
    • Events & Presentationer
    • Bolagsstyrning
      • Bolagsordning
      • Bolagsstämma
      • Styrelse
      • Bolagsstyrningsrapporter
      • Ledande befattningshavare
      • Valberedning
      • Ersättningar och ersättningsutskott
      • Revisorer och revisionsutskott
      • Vetenskapligt utskott
      • Vetenskapligt råd
    • Aktien
      • Aktieägare
      • Insiders
      • Investment calculator
      • Share price look-up
    • Finansiella rapporter
    • Finansiell kalender
    • Garanterad nyemission 2017
    • Tidigare emissioner
  • News & Events
    • Press Releases
    • Immunicum in the News
    • Events
Immunicum
  • Contact
  • Location
  • Sitemap
  • About
    • Company Profile
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
    • Careers
    • Contact
  • Technology
    • Immunicum’s Approach
    • Ilixadencel
    • Development Programs
    • Publications
  • Pipeline
    • Pipeline
    • Clinical Trial Information
  • Partnering
  • Investors
    • Overview
    • Press Releases
      • 2018
      • 2017
      • 2016
      • 2015
      • 2014
      • 2013
      • Subscribe
    • Events & Presentations
    • Corporate Governance
      • Articles of Association
      • General meeting
      • Board of directors
      • Corporate governance reports
      • Senior Executives
      • Nomination Committee
      • Remuneration and the remuneration committee
      • Auditors and audit committee
      • Scientific committee
      • Scientific Advisory Board
    • Shareholder & Stock Info
      • Shareholders
      • Insider
      • Investment calculator
      • Share price look-up
    • Financial Reports
    • Financial calendar
    • SECURED RIGHTS ISSUE 2017
    • Downloads
    • Contacts
  • Investerare (SE)
    • Översikt
    • Pressmeddelanden
      • 2018
      • 2017
      • 2016
      • 2015
      • 2014
      • 2013
      • Prenumerera
    • Events & Presentationer
    • Bolagsstyrning
      • Bolagsordning
      • Bolagsstämma
      • Styrelse
      • Bolagsstyrningsrapporter
      • Ledande befattningshavare
      • Valberedning
      • Ersättningar och ersättningsutskott
      • Revisorer och revisionsutskott
      • Vetenskapligt utskott
      • Vetenskapligt råd
    • Aktien
      • Aktieägare
      • Insiders
      • Investment calculator
      • Share price look-up
    • Finansiella rapporter
    • Finansiell kalender
    • Garanterad nyemission 2017
    • Tidigare emissioner
  • News & Events
    • Press Releases
    • Immunicum in the News
    • Events
You are here:HomeInvestorsCorporate Governance

Investors

Corporate Governance

Redeye AB has been appointed Certified Adviser to the Company.

Contact:

Telephone: +46 8 545 013 31

www.redeye.se

BOARD OF DIRECTORS MEETINGS

The Board of Directors shall hold a statutory meeting following election at the annual general meeting each year. At the statutory meeting, the following matters shall be dealt with:

  1. Adoption of rules of procedure for the Board of Directors.
  2. Adoption of instructions to the CEO. These state the responsibility and decision-making authority of the CEO and Board of Directors, respectively.
  3. Election of a chairman of the Board of Directors.
  4. Resolution regarding authority to sign for the company.

ADDITIONAL BOARD MEETINGS

The Board of Directors shall hold regular meetings. In addition to the statutory meeting, the Board shall hold at least four meetings during the year.

OVERALL RESPONSIBILITIES OF THE BOARD OF DIRECTORS AND THE CEO

The Board is responsible for the governance of the Company and its organisation.

The CEO handles the ongoing management in accordance with the guidelines and instructions established by the Board. The CEO is responsible for day-to-day operations of the Company. The Board of Directors’ shall primarily deal with overall and long term issues, as well as matters of an unusual character or otherwise of great importance. The Board of Directors shall make decisions regarding all issues that do not concern the ongoing management and where a decision by the Board is required by the Articles of Association.

Press releases

Choose which language you would like to receive the press release in:

Swedish English
Contact us
Gothenburg

Grafiska vägen 2
SE-412 63 Gothenburg
Sweden

Stockholm

Klarabergsviadukten 63
111 64 Stockholm
Sweden

Telephone

+46 31 41 50 52

Email

info@immunicum.com

Social
Links
  • Sitemap
  • Privacy & Cookie Policy

© 2002-2018 Immunicum AB. All rights reserved.

Designer mkmedia
To top

We use cookies to improve the user experience on Immunicum. Read more about Cookies

Approve